No photo of Kari Laiho

Kari Laiho

20172017
If you made any changes in Pure these will be visible here soon.

International and National Collaboration Publications and projects within past five years.

Publications 2017 2017

Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial

Vaananen, T., Vuolteenaho, K., Kautiainen, H., Nieminen, R., Mottonen, T., Hannonen, P., Korpela, M., Kauppi, M. J., Laiho, K., Kaipiainen-Seppanen, O., Luosujarvi, R., Uusitalo, T., Uutela, T., Leirisalo-Repo, M., Moilanen, E. & NEO-RACo Study Grp, 25 Aug 2017, In : PLoS One. 12, 8, 15 p., 0183294.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12months: results from the FIN-ERA cohort

Rannio, T., Asikainen, J., Hannonen, P., Yli-Kerttula, T., Ekman, P., Pirilä, L., Kuusalo, L., Mali, M., Puurtinen-Vilkki, M., Kortelainen, S., Paltta, J., Taimen, K., Kauppi, M., Laiho, K., Nyrhinen, S., Makinen, H., Isomaki, P., Uotila, T., Aaltonen, K., Kautiainen, H. & 1 othersSokka, T., 2017, In : Scandinavian Journal of Rheumatology. 46, 6, p. 425-431 7 p.

Research output: Contribution to journalArticleScientificpeer-review